Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 7/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.46 |
| ▸ | MGLL | Q99685 | 6/20 | 0.46 |
| ▸ | FAAH | O00519 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18918259 | 0.95 | PTGS1 (0.53) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL11033299 | 0.94 | PTGS1 (0.55) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL945656 | 0.94 | PTGS1 (0.55) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL9185109 | 0.94 | PTGS1 (0.55) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL946090 | 0.94 | PTGS1 (0.55) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL57249 | 0.94 | PTGS1 (0.55) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL157545 | 0.90 | PTGS1 (0.41) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL14107102 | 0.90 | PTGS1 (0.38) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL15991990 | 0.89 | PTGS1 (0.40) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL21385132 | 0.88 | MAPT (0.41) | PTGS1PTGS2MGLLFAAHALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6348 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4736955-A2 | EPCAM ANTIBODIES, ACTIVATABLE ANTIBODIES, AND IMMUNOCONJUGATES, AND USES THEREOF | ImmunoGen, Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4719485-A1 | ANTIBODY-DRUG CONJUGATES FOR TREATING INFECTIONS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) | Taimed Biologics Inc. (TW) | 2026-04-08 | — | — | EP | claimed |
| US-20260086088-A1 | BIOINKS, METHODS OF PRINTING AND RELATED USES | UNIV MCMASTER (CA) | 2026-03-26 | — | — | US | claimed |
| EP-4688828-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF | Jubilant DraxImage Inc. (CA) | 2026-02-11 | — | — | EP | claimed |
| EP-4676942-A1 | PROTAMINE MOLECULES AND USES THEREOF | The University of British Columbia (CA) | 2026-01-14 | — | — | EP | claimed |
| EP-3873512-B1 | EPCAM ANTIBODIES, ACTIVATABLE ANTIBODIES, AND IMMUNOCONJUGATES, AND USES THEREOF | IMMUNOGEN INC (US) | 2026-01-14 | — | — | EP | claimed |
| US-12509571-B2 | Rubber composition for a motor mount with fatigue resistance and a rubber for a motor mount including the same | HYUNDAI MOTOR COMPANY (KR) | 2025-12-30 | — | — | US | claimed |
| EP-4642491-A1 | METHOD FOR GLYCOPROTEIN MODIFICATION | Honeybear Biosciences Inc. (TW) | 2025-11-05 | — | — | EP | claimed |
| WO-2025226837-A1 | ANTI-BACTERIAL METALLOTHIONEIN ANTIBODIES AND USES THEREOF | UNIVERSITY OF CONNECTICUT (US) | 2025-10-30 | — | — | WO | claimed |
| US-12448425-B2 | Therapeutic peptides | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-10-21 | — | — | US | claimed |
| EP-0942996-B1 | THROMBOLYTIC AGENTS WITH ANTITHROMBOTIC ACTIVITY | DIATIDE INC (US) | 2007-01-03 | — | — | EP | claimed |
| EP-1689846-A2 | METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES, AND METHODS OF MAKING SAID CONJUGATES | Immunogen, Inc. (US) | 2006-08-16 | — | — | EP | claimed |
| US-20060154259-A1 | Diamond crystallites for biotechnological applications | ACADEMIA SINICA (TW) | 2006-07-13 | — | — | US | claimed |
| US-20050169933-A1 | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates | IMMUNOGEN, INC. | 2005-08-04 | — | — | US | claimed |
| WO-2005037992-A2 | METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES, AND METHODS OF MAKING SAID CONJUGATES | IMMUNOGEN, INC. (US) | 2005-04-28 | — | — | WO | claimed |
| US-6107272-A | CROSSLINKED DIMER POLYPEPTIDES WITH HIGHER POTENCY AND PROLONGED CIRCULATING HALF-LIFE FOR REDUCTION IN AMOUNTS ADMINISTERED TO ACHIEVE AN EFFECTIVE DOSAGE, FOR BINDING TO THERAPEUTIC PROTEINS | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 2000-08-22 | — | — | US | claimed |
| EP-0942932-A1 | MULTIMERIC ERYTHROPOIETIN WITH INCREASED BIOLOGICAL ACTIVITY | Beth Israel Deaconess Medical Center (US) | 1999-09-22 | — | — | EP | claimed |
| US-5919758-A | HYBRIDS; GENETIC ENGINEERING | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 1999-07-06 | — | — | US | claimed |
| WO-1998023643-A1 | MULTIMERIC ERYTHROPOIETIN WITH INCREASED BIOLOGICAL ACTIVITY | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 1998-06-04 | — | — | WO | claimed |
| US-5747446-A | ERYTHROPOIETIN POLYPEPTIDE DIMERS WITH CROSSLINKING AGENTS | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 1998-05-05 | — | — | US | claimed |